Information Journal Paper
APA:
Copy. (2018). Denosumab in transfusion-dependent thalassemia osteoporosis: A randomized, placebo-controlled, double-blind phase 2b clinical trial. Blood Advances, 2(21), 2837-2847. SID. https://sid.ir/paper/749834/en
Vancouver:
Copy. Denosumab in transfusion-dependent thalassemia osteoporosis: A randomized, placebo-controlled, double-blind phase 2b clinical trial. Blood Advances[Internet]. 2018;2(21):2837-2847. Available from: https://sid.ir/paper/749834/en
IEEE:
Copy, “Denosumab in transfusion-dependent thalassemia osteoporosis: A randomized, placebo-controlled, double-blind phase 2b clinical trial,” Blood Advances, vol. 2, no. 21, pp. 2837–2847, 2018, [Online]. Available: https://sid.ir/paper/749834/en